Skip to main content
Premium Trial:

Request an Annual Quote

NanoTherics Lands Funding from English Economic Development Agency

NEW YORK (GenomeWeb News) - NanoTherics said today that it has received a grant from Advantage West Midlands that it will use to advance its gene transfection technologies.
The Staffordshire, UK-based company was founded in 2007 and is based on technology developed at Keele University and the University of Florida. The company’s technology uses nanoparticles and magnetic fields in the delivery of DNA and other molecules into living cells, which could be used in gene therapy programs.
AWM is one of nine regional development agencies in England and it aims to fund programs creating jobs in the West Midlands.
The company plans to launch the magnefect-nano, a “flexible device which provides up to 1,000-fold better transfection efficiency than cationic lipid agents for short transfection times,” NanoTherics CEO Linda Cammish said in a statement.
NanoTherics did not disclose the amount of the grant from AWM.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.